Melissa Juliano, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 27158 Buckskin Trl, Harbeson, DE 19951 Phone: 443-786-2189 |
News Archive
According to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, patients suffering from chronic primary insomnia (PIs) have higher levels of brain activation compared to normal sleepers during a working memory test.
One of the many unknowns facing women who are diagnosed with breast cancer is predicting the likelihood that the cancer will spread to other parts of the body – metastasize.
EcoNugenics® is proud to introduce BreastDefend™, a new nutraceutical compound formulated specifically to promote and maintain breast health. Physician-formulated BreastDefend is crafted from eight exclusive, clinically tested compounds, including scientifically supported nutrients, herbs, and medicinal mushrooms.
Until now, researchers believed recurrent mutations (hotspot mutations) in cancer tumors were the important mutations (driver mutations) that promoted cancer progression.
Astellas today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis), life-threatening fungal infections predominantly occurring in immunocompromised patients.
› Verified 5 days ago